Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca first-in-class ovarian cancer drug wins EU approval
AstraZeneca first-in-class ovarian cancer drug wins EU approval
AstraZeneca first-in-class ovarian cancer drug wins EU approval
Submitted by
admin
on December 18, 2014 - 9:01am
Source:
Yahoo/Reuters
News Tags:
AstraZeneca
ovarian cancer
Europe
Lynparza
olaparib
Headline:
AstraZeneca first-in-class ovarian cancer drug wins EU approval
Do Not Allow Advertisers to Use My Personal information
